Recent advances of bispecific antibodies in solid tumors

Recent advances of bispecific antibodies in solid tumors

Abstract Cancer immunotherapy is the most exciting advancement in cancer therapy. Similar to immune checkpoint blockade and chimeric antigen receptor T cell (CAR-T), bispecific antibody (BsAb) is attracting more and more attention as a novel strategy of antitumor immunotherapy. BsAb not only offers...

Full description

Bibliographic Details
Main Authors: Shengnan Yu, Anping Li, Qian Liu, Xun Yuan, Hanxiao Xu, Dechao Jiao, Richard G. Pestell, Xinwei Han, Kongming Wu
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Journal of Hematology & Oncology
Subjects:
BsAb
Solid tumor
EpCAM
CEA
PSMA
HER family
Online Access:http://link.springer.com/article/10.1186/s13045-017-0522-z

Internet

http://link.springer.com/article/10.1186/s13045-017-0522-z

Similar Items